Precision CRISPR: Drug Discovery and Gene Therapy London 2018 is a conference dedicated to the future of CRISPR gene editing and the getting of CRISPR gene therapy into the clinic.
Precision CRISPR: Drug Discovery and Gene Therapy London 2018 covers topics such as:
- How the likes of GSK, Novartis, AstraZeneca and more, work towards improving the efficacy of functional screening and drug discovery
- The challenges in delivery & reducing off-target effects in ex vivo & in vivo gene therapies
- The most recent gene editing techniques and Cas variants poised to make precise gene editing all that more precise
